CLARIVATE PLC - 8-K Filing
Clarivate reports Q3 2026 results with $567.9M revenue and announces completion of Life Sciences & Healthcare segment divestiture for $488.4M. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits(d) Exhibits)
Tickers: $CLVT
Read the full article at SEC EDGAR
Part of the story IDEAYA Biosciences, Inc. - 8-K Filing (42 articles)